BackAmerican Oriental Bioengineering Overview

American Oriental Bioengineering Common Stock

American Oriental Bioengineering's common stock is $73K.

Get informed when a big investor buys or sells

+ Follow
Common Stock
$73181.00
↓ 0.17% YoYΔ $-127.00 vs prior year quarter

Peer trimmed avg / median

Loading

American Oriental Bioengineering Common Stock History

Loading

American Oriental Bioengineering vs. peers: Common Stock Comparison

Loading

American Oriental Bioengineering Common Stock Growth (YoY per quarter)

Latest change versus the prior comparable period (same company). Positive growth indicates new issuance/dilution; negative growth indicates reductions/buybacks.

Loading

American Oriental Bioengineering (AOBI) FAQ

American Oriental Bioengineering (AOBI) currently reports a common stock of $73K as of September 2013. That compares with $73K in the prior-year period — down 0.2% year over year. Use the charts on this page to explore American Oriental Bioengineering's common stock history and peer comparisons.

American Oriental Bioengineering's common stock decreased from $73K to $73K — a 0.2% year-over-year decrease (period ending September 2013). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

American Oriental Bioengineering reported $73K in common stock as of September 2013. That compares with $73K in the prior-year period — down 0.2% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current common stock of $73K, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for American Oriental Bioengineering, and consider following AOBI for alerts when major investors trade the stock.

American Oriental Bioengineering is classified in the Healthcare sector. On common stock, it currently shows $73K. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing AOBI with unrelated industries.